Investor mix
6 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Other / undisclosed | 3 | 50% |
Anti-cancer treatments that target the insulin-like growth factor-1 receptor signalling pathway
6 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Other / undisclosed | 3 | 50% |